Radiation recall--another call with tamoxifen

Area of Science:

• Oncology
• Dermatology
• Pharmacology

Background:

• Tamoxifen is a widely used adjuvant therapy for estrogen-receptor positive breast cancer.
• Cutaneous adverse events associated with tamoxifen therapy are generally considered infrequent.

Observation:

• This study reviewed 20 cases of tamoxifen-related skin adverse effects reported to the Swedish Adverse Drug Reaction Register (1979-1997).
• An additional 1160 skin side effects were analyzed from the World Health Organization's International Collaborative Programme on Drug Monitoring.
• A specific case of radiation recall associated with tamoxifen is detailed.

Findings:

• Analysis of reported cases indicates a spectrum of cutaneous adverse events linked to tamoxifen.
• The case report highlights successful use of toremifene, a tamoxifen analogue, as a second-line therapy in a patient experiencing radiation recall.
• No reactivation of radiation recall was observed during 18 months of toremifene treatment.

Implications:

• Understanding tamoxifen's cutaneous side effect profile is crucial for patient management.
• Toremifene may be a viable therapeutic option for patients who develop radiation recall during tamoxifen treatment.
• Further research into the dermatological effects of tamoxifen and its analogues is warranted.